Form 4 for MET MetLife
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001099219-22-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-24 | 2022-02-22 | MET | DEBEL MARLENE | EVP, CRO | F - Tax | $68.96 | -4,098 | 55.7K | -7% | -$282.6K |
| DM | 2022-02-24 | 2022-02-22 | MET | DEBEL MARLENE | EVP, CRO | A - Grant | — | +16.6K | 48.4K | +52% | — |
| D | 2022-02-24 | 2022-02-22 | MET | DEBEL MARLENE | EVP, CRO | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | F | D | 4,098 | $68.96 | 55,657 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-22 | A | A | 11,313 | — | 59,755 | D | — | — | (F2) Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. |
| 3 | Common | Common Stock | 2022-02-22 | A | A | 5,330 | — | 48,442 | D | — | — | (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. |
| 4 | Derivative | Employee Stock Options (right to buy) | 2022-02-22 | A | A | 15,986 | $0.00 | 15,986 | D | $68.96 · — to 2032-02-21 | 15,986 Common Stock | (F4) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. |